Global Bipolar Disorder Treatment Market 2025 | Major Players-AstraZeneca, Otsuka Holdings Co. Ltd., Abbott, Bristol-Myers Squibb Company, Merck KGaA, Teva Pharmaceutical Industries Ltd., Gedeon Richter Plc., H. Lundbeck A/S

The Global Bipolar Disorder Treatment Market was divided into different sections by product, application, end user, and region. The global market is expected to witness a relatively higher growth rate during the forecast period for all the industry according to the Global Bipolar Disorder Treatment Market report. The Global Bipolar Disorder Treatment Market is changing due to key players and brands making movements such as developments, product launches, joint ventures, merges and accusations that in turn change the view of the industry’s global face.Support for SWOT analysis and Porter’s Five Forces reporting tool will help the reader analyze market drivers and limitations.

Market Analysis: Global Bipolar Disorder Treatment Market

With the rise of stress among the adult population of the world, Bipolar Disorder are on the rise and the unmet need  to diagnose or treat the disease is causing the market to research, develop and innovate new ways. This surge will make the market rise at a CAGR of 2.5%, from its initial estimated value of USD 4.38 billion in 2017 to USD 5.34 billion by 2025.

FREE | Get a Copy of Sample Report Now! @

Key Market Competitors: Global Bipolar Disorder Treatment Market

Few of the major competitors currently working on the Bipolar Disorder Treatment market are-GlaxoSmithKline plc., Pfizer Inc., Janssen Global Services LLC., Eli Lilly and Company, ALLERGAN, Novartis AG, AbbVie Inc., AstraZeneca, Otsuka Holdings Co. Ltd., Abbott, Bristol-Myers Squibb Company, Merck KGaA, Teva Pharmaceutical Industries Ltd., Gedeon Richter Plc., H. Lundbeck A/S, REPLIGEN CORPORATION, Validus Pharmaceuticals LLC., Sumitomo Dainippon Pharma Co. Ltd. and Astellas Pharma Inc..

Market Definition: Global Bipolar Disorder Treatment Market

Bipolar Disorder, also called manic depression, is a type of mental disorder that causes frequent and unpredicted mood swings in the patients. It has been termed as Bi-Polar due to the extreme changes or two different sides that the person suffers in this disease. Recent researches have showed that it is a genetic disease and is transferred through genes. There are certain genes responsible for the development of said disease.

FREE | Request For TOC@

Table of Contents:

  1. Introduction
  2. Market Segmentation
  3. Market Overview
  4. Executive Summary
  5. Premium Insights
  6. Global, By Component
  7. Product Type
  8. Delivery
  9. Industry Type
  10. Geography
    • Overview
    • North America
    • Europe
    • Asia-Pacific
    • South America
    • Middle East & Africa
  11. Company Landscape
  12. Company Profiles
  13. Related Reports


Segmentation: Global Bipolar Disorder Treatment Market

By Type

Bipolar I

Bipolar II


By Drug Class



Mood Stabilizers



By Mechanism of Action

Monoamine oxidase inhibitors

Serotonin-norepinephrine reuptake inhibitors

Selective serotonin reuptake inhibitors

Beta blockers

Tricyclic antidepressants


By Treatment

ECT (Electroconvulsive therapy)

TMS (Transcranial magnetic stimulation)

Others (Psychotic therapies)

By Geography

North America



Middle East and Africa

Key Development in the Market: Global Bipolar Disorder Treatment Market

In a study in 2016, a gene called IEG which was commonly known as EGR3 was reported responding under environmental events and stressful conditions and repressed in the brains of the patients suffering from Bipolar disorder. The research suggests that both EGR3 and brain-derived neurotrophic factor may play an important role in the impaired cellular resilience seen in bipolar disorder.

In 2016, Salk Institute for Biological Studies and The Johns Hopkins University launched together an initiative to develop new studies and drug screening methods for schizophrenia and bipolar disorder worth USD 15.4 million.

Competitive Analysis: Global Bipolar Disorder Treatment Market

The Global Bipolar Disorder Treatment Market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of bipolar disorder treatment market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Key Insights in the report:

  • The key market players are analyzed and their effects on the market is also observed
  • Market analysis is conducted for the forecast period of 2018 to 2025, and the market segmentations are observed during that period
  • The market drivers and restraints have been clearly analyzed for the effect that they have over the market in the forecast period of 2018 to 2025

Market Drivers:

Government support and awareness programs organized are increasing the detection and diagnostic capabilities of the industry, increasing the market share and growth

Advancements in combination drugs and therapeutic market is one of the major reasons for the growth of the industry

Market Restraints:

  • Side effects associated with therapies for its treatment are one of the major factors halting the market growth
  • Many of the patents are expiring for the blockbuster drugs in the market, and are therefore causing the market to be flooded with generic drugs, this factor will seriously cutoff the market growth

FREE | Speak to Analyst and Get Free Customized Information about Report @

About Us:

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market. Data Bridge endeavors to provide appropriate solutions to the complex business challenges and initiates an effortless decision-making process.

Contact Us-

Data Bridge Market Research

US: +1-888-387-2818



Related Articles

Leave a Reply

Your email address will not be published. Required fields are marked *